Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

CanSino's inhaled COVID-19 vaccine gets emergency use approval in China

China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

Reuters

Second Covid booster jab approved in UK ahead of winter vaccine programme

It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK

Evening Standard

New 'second generation' Pfizer Covid vaccine approved ahead of booster programme

The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

A new vaccine which protects against two strains of covid has been approved for the NHS to use this autumn

It targets both the original strain of coronavirus and the Omicron variant

Manchester Evening News

Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator

The vaccine targets both the original strain of coronavirus and the Omicron variant.

The Independent UK

US-level mortality? Sounding the alarm about fentanyl overdose in Australia

Deaths from the powerful opioid, along with pethidine and tramadol, are up a staggering 1,275% since 2006. A new report warns without ‘decisive action’ a crisis looms

The Guardian - AU

Pfizer criticised by conservatives for excluding white and Asian applicants from scholarship programme

Company says scheme will boost minority representation

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

FDA still skeptical of ALS drug ahead of high-stakes meeting

The U.S. Food and Drug Administration has posted another negative review of a closely watched drug for the deadly neurodegenerative disease ALS

The Independent UK

‘Completely new’ COVID strains possible in winter: EU drug agency

Existing vaccines and adaptive ones should protect people from serious illness and death, the EU agency says.

Al Jazeera

Is Cannabis Legalization The End For Pharma Stocks? New Study Predicts Billions In Losses

Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study cond

Benzinga

EU regulator gives green light to omicron booster vaccines

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

Radio France Internationale

New omicron COVID-19 boosters are coming. Here’s what you need to know

DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.

The Denver Post

"Game-changer" Paxlovid turns into pandemic enigma

Paxlovid goes from COVID game-changer to pandemic enigma

Axios

Alliance Pharma boss faces disqualification after CMA probe

The healthcare firm denies conspiring to restrict the supply of anti-sickness drugs to the NHS

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

CDC recommends updated COVID-19 boosters

The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.

Bangkok Post

Innobic in talks with potential partner

Innobic (Asia) Co, the life science arm of national oil and gas conglomerate PTT Plc, is seeking a new business partner in Iceland in a fresh move to produce medicines to treat cancer.

Benzinga

Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics

Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog.

The Independent UK

CDC advisers weigh who needs updated COVID booster and when

Government advisers are debating who should should get new updated COVID-19 boosters and when

Get all your
news in one place.

100's of premium titles.
One news app.

Reuters

EU regulator backs use of Novavax COVID shot as a booster

The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.

Bangkok Post

EU regulator approves Omicron vaccines

The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.

Benzinga

Everest Medicines Descends To New Depths On String Of Bad News

Key Takeaways: The CEO of Everest Medicines resigned two days after the company announced its loss grew sharply in the first half of the year The company also lost an important potential new revenue source after transferring rights for one of its core products to another company By Emily Chan

The Independent UK

EU regulator clears tweaked versions of COVID vaccines

The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant

ABC News

Brisbane biotech firm Ellume puts Australian arm into administration

Ellume rose to prominence last year when it announced a $300 million deal to provide COVID-19 home test kits to the US Department of Defense.

Los Angeles Times

Michael Hiltzik: In blow to public health, judge tosses FDA lawsuit targeting a clinic offering unproven stem cell treatments

A federal judge in Riverside, California, declared a stem cell treatment firm operating in the state to be exempt from Food and Drug Administration regulations, opening the door to the further proliferation of clinics offering therapies the FDA says are scientifically unproven and potentially dangerous.

Benzinga

Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy

Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.

1 … 132 133 134 135

People

Buranin Rattanasombat

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

338 stories

MHRA

319 stories

Department of Defense

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.